Austar Lifesciences Ltd.'s total assets for Q4 2025 were ¥2.13B, an increase of 4.96% from the previous quarter. HK:6118 total liabilities were ¥1.30B for the fiscal quarter, a 7.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.